Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers.

Autor: Jackson-Thompson BM; Department of Microbiology and Immunology, Uniformed Services University of the Health Science, Bethesda, MD, USA. Belinda.Jackson.ctr@usuhs.edu.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA. Belinda.Jackson.ctr@usuhs.edu., Goguet E; Department of Microbiology and Immunology, Uniformed Services University of the Health Science, Bethesda, MD, USA.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA., Laing ED; Department of Microbiology and Immunology, Uniformed Services University of the Health Science, Bethesda, MD, USA., Olsen CH; Department of Preventive Medicine & Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, USA., Pollett S; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA.; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA., Hollis-Perry KM; Clinical Trials Center, Naval Medical Research Center, Silver Spring, MD, USA., Maiolatesi SE; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA.; Clinical Trials Center, Naval Medical Research Center, Silver Spring, MD, USA., Illinik L; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA.; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA., Ramsey KF; Clinical Trials Center, Naval Medical Research Center, Silver Spring, MD, USA.; General Dynamics Information Technology, Falls Church, VA, USA., Reyes AE; Clinical Trials Center, Naval Medical Research Center, Silver Spring, MD, USA.; General Dynamics Information Technology, Falls Church, VA, USA., Alcorta Y; Clinical Trials Center, Naval Medical Research Center, Silver Spring, MD, USA.; General Dynamics Information Technology, Falls Church, VA, USA., Wong MA; Clinical Trials Center, Naval Medical Research Center, Silver Spring, MD, USA.; General Dynamics Information Technology, Falls Church, VA, USA., Davies J; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA.; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA., Ortega O; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA.; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA., Parmelee E; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA., Lindrose AR; Department of Microbiology and Immunology, Uniformed Services University of the Health Science, Bethesda, MD, USA.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA., Moser M; Department of Microbiology and Immunology, Uniformed Services University of the Health Science, Bethesda, MD, USA.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA., Graydon E; Department of Microbiology and Immunology, Uniformed Services University of the Health Science, Bethesda, MD, USA., Letizia AG; Infectious Disease Directorate, Naval Medical Research Center, Silver Spring, MD, USA., Duplessis CA; Clinical Trials Center, Naval Medical Research Center, Silver Spring, MD, USA., Ganesan A; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA.; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA., Pratt KP; Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA., Malloy AM; Department of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA., Scott DW; Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA., Anderson SK; Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Snow AL; Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA., Dalgard CL; Department of Anatomy, Physiology, and Genetics, and The American Genome Center, Uniformed Services University of the Health Sciences, Bethesda, MD, USA., Powers JH 3rd; Clinical Research Directorate, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Tribble D; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA., Burgess TH; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA., Broder CC; Department of Microbiology and Immunology, Uniformed Services University of the Health Science, Bethesda, MD, USA., Mitre E; Department of Microbiology and Immunology, Uniformed Services University of the Health Science, Bethesda, MD, USA. Edward.Mitre@usuhs.edu.

Publikováno v: BMC infectious diseases [BMC Infect Dis] 2021 Jun 09; Vol. 21 (1), pp. 544. Date of Electronic Publication: 2021 Jun 09.